Teachers Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-72,346
Closed -$1.3M 3090
2017
Q4
$1.3M Buy
72,346
+3,768
+5% +$46.4K ﹤0.01% 2100
2017
Q3
$809K Buy
68,578
+79
+0.1% +$886 ﹤0.01% 2353
2017
Q2
$719K Buy
68,499
+1,953
+3% +$19.9K ﹤0.01% 2420
2017
Q1
$732K Sell
66,546
-418,472
-86% -$4.86M ﹤0.01% 2334
2016
Q4
$6.57M Sell
485,018
-17,711
-4% -$247K 0.01% 1139
2016
Q3
$6.19M Buy
502,729
+25,500
+5% +$300K 0.01% 1128
2016
Q2
$5.24M Buy
477,229
+53,838
+13% +$603K 0.01% 1154
2016
Q1
$4.63M Buy
423,391
+117,700
+39% +$1.49M 0.01% 1167
2015
Q4
$5.29M Buy
305,691
+20,968
+7% +$376K 0.01% 1115
2015
Q3
$5.66M Buy
284,723
+244,818
+614% +$5.61M 0.01% 1071
2015
Q2
$656K Buy
39,905
+14,389
+56% +$249K ﹤0.01% 2361
2015
Q1
$397K Buy
25,516
+3,299
+15% +$51.1K ﹤0.01% 2570
2014
Q4
$317K Hold
22,217
﹤0.01% 2689
2014
Q3
$144K Hold
22,217
﹤0.01% 2989
2014
Q2
$153K Buy
22,217
+1,085
+5% +$7.67K ﹤0.01% 2991
2014
Q1
$151K Hold
21,132
﹤0.01% 2962
2013
Q4
$199K Hold
21,132
﹤0.01% 2864
2013
Q3
$132K Buy
21,132
+3,650
+21% +$22.8K ﹤0.01% 2953
2013
Q2
$115K Buy
+17,482
New +$139K ﹤0.01% 2969

Other funds holding SCMP

Teachers Advisors's SCMP Position: Q1 2018 in Review

Teachers Advisors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 72,346 shares — an estimated $1.3M sold.

Teachers Advisors first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $6.57M in Q4 2016. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Teachers Advisors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Teachers Advisors sold 72,346 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.3M.
  • Teachers Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
  • Teachers Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $6.57M in Q4 2016.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Teachers Advisors's 13F filing for Q1 2018, filed 14 May 2018.